Non-viral vector as vaccine carrier (Q36226802)

12 August 2017

1 reference

title

Non-viral vector as vaccine carrier (English)

1 reference

12 August 2017

Weihsu Claire Chen

1

1 reference

12 August 2017

Leaf Huang

series ordinal

2

1 reference

12 August 2017

publication date

1 January 2005

1 reference

12 August 2017

1 reference

12 August 2017

volume

54

1 reference

12 August 2017

page(s)

315-337

1 reference

DNA vaccination: transfection and activation of dendritic cells as key events for immunity

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2805%2954013-6

7 January 2021

Liposomes as immunological adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2805%2954013-6

7 January 2021

Liposomes as carriers of antigens and adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2805%2954013-6

7 January 2021

A novel liposomal influenza vaccine (INFLUSOME-VAC) containing hemagglutinin-neuraminidase and IL-2 or GM-CSF induces protective anti-neuraminidase antibodies cross-reacting with a wide spectrum of influenza A viral strains.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2805%2954013-6

7 January 2021

Induction of a cytotoxic T lymphocyte (CTL) response to plasmid DNA delivered via Lipodine liposomes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2805%2954013-6

7 January 2021

Evaluation of the protective immunogenicity of the N, P, M, NV and G proteins of infectious hematopoietic necrosis virus in rainbow trout oncorhynchus mykiss using DNA vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2805%2954013-6

7 January 2021

A comparative study of different presentation strategies for an HIV peptide immunogen.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2805%2954013-6

7 January 2021

The dendritic cell and human cancer vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2805%2954013-6

7 January 2021

Plasmid DNA is superior to viral vectors for direct gene transfer into adult mouse skeletal muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2805%2954013-6

7 January 2021

Direct gene transfer into skeletal muscle in vivo: factors affecting efficiency of transfer and stability of expression

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2805%2954013-6

7 January 2021

Lipid–protamine–DNA-mediated antigen delivery to antigen-presenting cells results in enhanced anti-tumor immune responses

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2805%2954013-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS0065-2660%2805%2954013-6

1 reference

7 January 2021

Circumventing genetic restriction of protection against malaria with multigene DNA immunization: CD8+ cell-, interferon gamma-, and nitric oxide-dependent immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2805%2954013-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS0065-2660%2805%2954013-6

1 reference

7 January 2021

Biodegradable microspheres as a vaccine delivery system

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2805%2954013-6

7 January 2021

Rabies DNA vaccine in the horse: strategies to improve serological responses

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2805%2954013-6

7 January 2021

Vaccination of puppies with a lipid-formulated plasmid vaccine protects against a severe canine distemper virus challenge

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2805%2954013-6

7 January 2021

Liposomal malaria vaccine in humans: a safe and potent adjuvant strategy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2805%2954013-6

7 January 2021

Potentiation of cationic liposome-mediated gene delivery by polycations

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2805%2954013-6

7 January 2021

DNA vaccines against malaria: immunogenicity and protection in a rodent model

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2805%2954013-6

7 January 2021

Immunopotentiating reconstituted influenza virus virosome vaccine delivery system for immunization against hepatitis A

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2805%2954013-6

7 January 2021

Use of novel adjuvants and delivery systems to improve the humoral and cellular immune response to malaria vaccine candidate antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2805%2954013-6

7 January 2021

Immunological adjuvants: a role for liposomes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2805%2954013-6

7 January 2021

Engineering liposomes for drug delivery: progress and problems

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2805%2954013-6

7 January 2021

Genetic vaccines: strategies for optimization

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2805%2954013-6

7 January 2021

Entrapment of proteins in liposomes prevents allergic reactions in pre-immunised mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2805%2954013-6

7 January 2021

A role for liposomes in genetic vaccination.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2805%2954013-6

7 January 2021

Liposome-mediated DNA vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2805%2954013-6

7 January 2021

High yield incorporation of plasmid DNA within liposomes: effect on DNA integrity and transfection efficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2805%2954013-6

7 January 2021

Immunity against cancer: lessons learned from melanoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2805%2954013-6

7 January 2021

On the key role of secondary lymphoid organs in antiviral immune responses studied in alymphoplastic (aly/aly) and spleenless (Hox11(-)/-) mutant mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2805%2954013-6

7 January 2021

DNA vaccines: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2805%2954013-6

7 January 2021

In vivo gene transfer via intravenous administration of cationic lipid-protamine-DNA (LPD) complexes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2805%2954013-6

7 January 2021

Characterization of cationic lipid-protamine-DNA (LPD) complexes for intravenous gene delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2805%2954013-6

7 January 2021

Recombinant adeno-associated virus expressing human papillomavirus type 16 E7 peptide DNA fused with heat shock protein DNA as a potential vaccine for cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2805%2954013-6

7 January 2021

DNA immunization protects nonhuman primates against rabies virus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2805%2954013-6

7 January 2021

Naive and memory T cells show distinct pathways of lymphocyte recirculation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2805%2954013-6

7 January 2021

Intralymphatic immunization enhances DNA vaccination.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2805%2954013-6

7 January 2021

Incorporation of hepatitis-B surface antigen (HBsAg) into liposomes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2805%2954013-6

7 January 2021

Induction of protective immunity against herpes simplex virus with DNA encoding the immediate early protein ICP 27.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2805%2954013-6

7 January 2021

DNA vaccination against persistent viral infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2805%2954013-6

7 January 2021

Selection of potent immunological adjuvants for vaccine construction

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2805%2954013-6

7 January 2021

Genetic, cellular and immune approaches to disease therapy: past and future

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2805%2954013-6

7 January 2021

Immune surveillance against a solid tumor fails because of immunological ignorance

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2805%2954013-6

7 January 2021

Liposome-mediated DNA vaccination: the effect of vesicle composition

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2805%2954013-6

7 January 2021

Delivery of lipids and liposomal proteins to the cytoplasm and Golgi of antigen-presenting cells. mangala.rao@na.amedd.army.mil

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2805%2954013-6

7 January 2021

Dendritic cells as adjuvants for immune-mediated resistance to tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2805%2954013-6

7 January 2021

Protection against malaria by immunization with plasmid DNA encoding circumsporozoite protein

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2805%2954013-6

7 January 2021

International meeting on the nucleic acid vaccines for the prevention of infectious disease and regulating nucleic acid (DNA) vaccines. Natcher Conference Center NIH, Bethesda, MD 5-8 February, 1996.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2805%2954013-6

7 January 2021

Vaccination against tuberculosis by DNA injection

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2805%2954013-6

7 January 2021

DNA vaccine for West Nile virus infection in fish crows (Corvus ossifragus).

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2805%2954013-6

7 January 2021

Heterologous protection against influenza by injection of DNA encoding a viral protein

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2805%2954013-6

7 January 2021

Vaccination with HPV16 peptides of patients with advanced cervical carcinoma: clinical evaluation of a phase I-II trial

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2805%2954013-6

7 January 2021

Gene inoculation generates immune responses against human immunodeficiency virus type 1

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2805%2954013-6

7 January 2021

Enhancement of antitumor immunity by prolonging antigen presentation on dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2805%2954013-6

7 January 2021

LPD lipopolyplex initiates a potent cytokine response and inhibits tumor growth

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2805%2954013-6

7 January 2021

Systemic administration of LPD prepared with CpG oligonucleotides inhibits the growth of established pulmonary metastases by stimulating innate and acquired antitumor immune responses

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2805%2954013-6

7 January 2021

Immunization for Ebola virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2805%2954013-6

7 January 2021

Antigen localisation regulates immune responses in a dose- and time-dependent fashion: a geographical view of immune reactivity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2805%2954013-6

7 January 2021

Protection of mice against Plasmodium yoelii sporozoite challenge with P. yoelii merozoite surface protein 1 DNA vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2805%2954013-6

7 January 2021

DNA vaccines -- a modern gimmick or a boon to vaccinology?

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2660%2805%2954013-6

7 January 2021

10.1016/S0065-2660(05)54013-6

Identifiers

DOI

1 reference

12 August 2017

1 reference